Publications
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma2016 | First Faculty of Medicine, Second Faculty of Medicine
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | First Faculty of Medicine
- Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis2013 | Central Library of Charles University, First Faculty of Medicine
- The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms2013 | Central Library of Charles University, First Faculty of Medicine
- Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL)2013 | First Faculty of Medicine
- Resistance to TRAIL in mantle cell lymphoma cells is associated with the decreased expression of purine metabolism enzymes2013 | First Faculty of Medicine
- N-Phosphonocarbonylpyrrolidine Derivatives of Guanine: A New Class of Bi-Substrate Inhibitors of Human Purine Nucleoside Phosphorylase2012 | First Faculty of Medicine
- The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies2010 | First Faculty of Medicine
- TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNF alpha but not to idarubicin and cytarabine2009 | First Faculty of Medicine
- Cell Death Signalling Pathways in the Pathogenesis and Therapy of Haematologic Malignancies: Overview of Therapeutic Approaches2006 | First Faculty of Medicine
Loading network view...
